Business

Analyst Presentation

Analyst Presentation.

articleAvacta Group PlcMarch 31, 20093/company/avacta-group-plc/news/analyst-presentation-9
Analyst Presentation

About this update from Avacta Group Plc

[{"type":"text","content":"\n \n Avacta Group plc \n\n Analyst Presentation \n\nAvacta Group plc (\"Avacta\" or the \"Company\"), which is providing innovative,\nhigh value technologies and services to the pharmaceutical and diagnostics\nmarkets, announces an analyst presentation to showcase the Company's\ntechnology. The presentation will be held at 10:30am on 23 April at a location\nin the City of London.\n\nThose wishing to attend are asked to contact Kathy Boate at Haggie Financial\nLLP.\n\n 31 March 2009\n\nEnquiries:\n\nHaggie Financial LLP Tel: 020 7417 8989 \n \nNicholas Nelson/Kathy Boate [email protected] \n \nNominated Advisor: Tel: 020 7776 6550 \n \nDaniel Stewart & Company plc \n \nLindsay Mair/Charlotte Stranner \n \nwww.danielstewart.co.uk \n \nNovum Securities Limited Tel: 020 7562 4700 \n \nHenry Turcan \n\nNotes to Editors:\n\nAbout Avacta:\n\nAvacta was spun-out from the University of Leeds in 2004 by its current\nmanagement team as a biophysics company, with the aim of combining the\ndisciplines of physics and biology to develop innovative technologies and\nexpert technical services to address needs in the pharmaceutical, defence and\nclinical diagnostics markets.\n\nAvacta has a core bio-analytical technology development programme addressing\nthe needs of the biopharmaceutical sector to fully characterise their new\nproducts at the earliest stage in their development to reduce the risk of late\nstage failure. High value solutions in clinical diagnostics are also being\ntargeted for these core bio-analytical technologies and for Avacta's trace gas\nanalysis technology as well as opportunities in industrial and military sensing\napplications.\n\nA successful and growing part of the Avacta business model is its technical\nservices arm, Avacta Analytical Limited, which is focused on providing leading\nedge contract research to the biopharmaceutical and healthcare/personal-care\nmaterials sectors. Avacta joined AIM in August 2006.\n\n\n \n ","length":3058,"tagName":"div"}]

More updates from Avacta Group Plc